U.S. government proposes more transparency in clinical trials

November 19, 2014 6:07 PM

11 0

(Reuters) - U.S. health officials on Wednesday proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions, addressing concerns that data crucial to patients and physicians is kept secret.

The rules, which are open for public comment until Feb. 19, apply to the database ClinicalTrials.gov, operated by the National Institutes of Health (NIH).

Read more

To category page